Field safety notices: THERADIAG
Group or brand name: several entities registered in EUDAMED may be concerned. The exact entity is named in each notice, at the source.
3 authority publications by 2 authorities, from 18 Aug 2021 to 24 May 2023.
Latest notice: 24 May 2023, ANSM, Réactifs Fidis Vasculitis, Fidis Celiac IgA & Fidis Celiac IgG
Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by THERADIAG or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.
2 distinct corrective actions.
- ANSMFranceofficial source: Réactifs Fidis Vasculitis, Fidis Celiac IgA & Fidis Celiac IgG, ANSM, 2023-05-24Réactifs Fidis Vasculitis, Fidis Celiac IgA & Fidis Celiac IgG
Source : ANSM, informations de sécurité · collected 16 Nov 2026
Corrective action: 2 publications by AEMPS, ANSM, from 18 Aug 2021 to 7 Oct 2021
- Kit i-Tracker infliximab, referencia CTI 002-100
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026
- Réactif I-Tracker Infliximab
Source : ANSM, informations de sécurité · collected 16 Nov 2026